PO.CL11.02 · 临床研究

家庭步行干预对处于主动监测的前列腺癌男性血清代谢组学特征的影响

Effects of a home-based walking intervention on serum metabolomic profiles in men with prostate cancer on active surveillance

海报缩略图:家庭步行干预对处于主动监测的前列腺癌男性血清代谢组学特征的影响
编号 1237 展板 11 时间 4/19 02:00–05:00 区域 Section 48 主讲 June Chan, DSc
分会场 Survivorship, Supportive Care, and Quality of Life in Oncology
查看 PDF 下载 PDF 🔒 查看 / 下载完整 PDF 需登录并开通下载套餐 · 查看套餐 / 开通 AACR 官方页面

作者与单位 Authors & Affiliations

Rebecca E. Graff1, Ritu Roy1, Oliver Fiehn2, Adam Olshen1, Erin Van Blarigan1, Stacey Kenfield1, Jeffry P. Simko1, Anthony Luke1, Lee Jones3, Matthew R. Cooperberg1, Peter R. Carroll1, June M. Chan1

1University of California, San Francisco, San Francisco, CA,2University of California, Davis, Davis, CA,3City of Hope, Duarte, CA

摘要 Abstract

中文摘要
引言:长期运动影响健康个体代谢组的潜力已得到充分证实。鉴于前列腺癌的代谢基础,探究长期运动是否同样改变患病男性的代谢组具有重要意义。本研究是最早刻画前列腺癌个体代谢变化的研究之一,比较了被分配到家庭步行计划者与被分配到印刷版身体活动建议材料者。 方法:51名处于主动监测的前列腺癌男性被随机分配到运动组或对照组干预。在West Coast Metabolomics Center对基线时和16周干预后采集的血清样本进行了初级代谢、复杂脂质和生物胺的代谢组学分析;运动组22名参与者和对照组23名参与者成功获得了数据。为识别与干预相关的代谢变化差异,我们进行了层次聚类分析,并拟合了包含组别×时间交互项的混合效应模型。 结果:层次聚类显示,16周时运动组与对照组之间的代谢特征分离有限。虽然在1220种已命名的代谢物中,没有一种在两组之间的变化差异达到统计学显著性(q < 0.10),但有85种(7.0%)达到名义显著性(p < 0.05)。在p值最小的15种代谢物中,有六种(40%)为鞘脂——特别是鞘磷脂——尽管鞘脂仅占所有已命名代谢物的11%。这六种鞘磷脂在运动组随时间的下降幅度均大于对照组。 结论:尽管代谢特征总体上未发生显著改变,但步行干预可能促进鞘磷脂的减少,从而使脂质信号转向增强线粒体功能和减少炎症的通路。此类变化与运动可能有利地影响前列腺癌生物学的、具有生物学合理性的机制相一致,即使在缺乏广泛代谢组学变化的情况下亦然。
查看英文原文 English abstract
Introduction: The potential for long-term exercise to affect the metabolome in healthy individuals is well established. Given the metabolic underpinnings of prostate cancer, it is important to investigate whether long-term exercise similarly alters the metabolome in disease-affected men. This study is among the first to characterize metabolic changes in individuals with prostate cancer, comparing those assigned to a home-based walking program to those assigned to printed materials with physical activity recommendations. Methods: Fifty-one men with prostate cancer on active surveillance were randomly allocated to the exercise or control intervention. Metabolomic profiling of primary metabolism, complex lipids, and biogenic amines was performed at the West Coast Metabolomics Center on serum samples collected at baseline and after the 16-week interventions; data were successfully generated for 22 participants in the exercise arm and 23 participants in the control arm. To identify intervention-related differences in metabolic changes, we performed hierarchical clustering and fit mixed-effects models including an arm x time interaction. Results: Hierarchical clustering indicated limited separation in metabolic profiles between the exercise and control groups at 16 weeks. Although none of the 1,220 named metabolites exhibited statistically significant differences in change between the two groups ( q <0.10), 85 (7.0%) demonstrated nominal significance ( p <0.05). Among the 15 metabolites with the smallest p-values, six (40%) were sphingolipids - specifically sphingomyelins - though sphingolipids comprised only 11% of all named metabolites. All six sphingomyelins decreased more over time in the exercise group than in the control group. Conclusions: Although metabolic profiles were not significantly altered overall, a walking intervention may promote the reduction of sphingomyelins, thereby shifting lipid signaling toward pathways that enhance mitochondrial function and reduce inflammation. Such changes are consistent with biologically plausible mechanisms through which exercise could favorably influence prostate cancer biology, even in the absence of broad metabolomic shifts.
利益披露 Disclosure
R. E. Graff, None.. R. Roy, None.. O. Fiehn, None.. A. Olshen, None.. E. Van Blarigan, None.. S. Kenfield, None.. J. P. Simko, None. A. Luke, Sportzpeak Inc Stock. L. Jones, None.. M. R. Cooperberg, None.. P. R. Carroll, None. J. M. Chan, Adela Inc. Other, Spouse is a full-time employee of Adela Inc.

← 返回 AACR 2026 检索